Streetbeat News

Stock Prices

ARI

Apollo Commercial Real Estate (NYSE:ARI) reported a Q3 2024 GAAP EPS of $(0.69), missing the analyst consensus estimate of $(0.42) by 64.29%.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 8:23 pm

AMGN

Amgen has released its fiscal year 2024 earnings per share (EPS) guidance, projecting a range of $19.20 to $20.00. This is compared to the previous EPS of $19.49.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 8:22 pm

NTGR

Netgear has provided a Q4 sales forecast ranging from $160 million to $175 million, which is slightly below the market estimate of $174.60 million.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 8:22 pm

CMPR

Cimpress reported a Q1 EPS loss of $(0.50), missing the $0.29 estimate, but sales of $804.97M beat the $798.92M estimate. EPS decreased by 394.12% from last year, while sales increased by 6.30%.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 8:22 pm

DASH

DoorDash projects its Q4 Marketplace GOV to be between $20.6 billion and $21.0 billion, with an adjusted EBITDA of $525 million to $575 million. The company expects stock-based compensation to be $1.13 billion, RSU issuances around 6.0 million, and depreciation and amortization at $562 million.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 8:22 pm

IRT

Independence Realty Trust reported Q3 2024 earnings per share of $0.29, missing the analyst estimate of $0.30. Sales were $159.860 million, slightly below the $159.939 million estimate, and down 5.06% from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 8:22 pm

AIN

Albany Intl (NYSE:AIN) reported Q3 2024 earnings per share of $0.80, surpassing the analyst estimate of $0.57, but sales of $298.39M fell short of the $301.10M estimate. EPS decreased by 21.57% from last year, while sales increased by 6.15%.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 8:21 pm

MX

MagnaChip Semiconductor reported a Q3 2024 adjusted EPS of $(0.34), missing the estimate of $(0.19), but sales of $66.460M beat the $64.033M estimate.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 8:21 pm

NVST

Envista Holdings reported Q3 2024 earnings of $0.12 per share, surpassing the $0.09 estimate, and sales of $601 million, exceeding the $590.32 million estimate. Despite beating estimates, sales decreased by 4.80% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 8:21 pm

HIMS

NVO

Hims & Hers Health Inc. (NYSE:HIMS) shares fell after the FDA announced the availability of Novo Nordisk's (NYSE:NVO) drugs Ozempic and Wegovy, which may end the demand for compounded versions that Hims & Hers benefited from.

Portfolio Pulse from Vaishali Prayag

October 30, 2024 | 8:20 pm